Besides cyclin D1/bcl-1, the Mayo group study showed a subset of RDD cases also expressed p16 (64%), Factor XIIIa (30%) and phosphorylated extracellular signal-related kinase (45%) [43]. This evidence concerns the gene F13A1 and sinus histiocytosis with massive lymphadenopathy.